2023 ESMO express: research on changing clinical practice for prostate cancer / 中华泌尿外科杂志
Chinese Journal of Urology
; (12): 885-888, 2023.
Article
de Zh
| WPRIM
| ID: wpr-1028366
Bibliothèque responsable:
WPRO
ABSTRACT
The 2023 European Society for Medical Oncology (ESMO) was held recently. In this conference, numbers of cutting-edge studies were discussed and published including advances in diagnosis and treatment, especially in prostate cancer. Studies that may influence clinical treatment decisions were summarized in this article, including timing of radiotherapy after radical prostatectomy, Enzalutamide in biochemically recurrent prostate cancer, predictive factors of novel hormonal therapies in metastatic hormone-sensitive prostate cancer, and the value of osteoprotective agent. The purpose of this article was to help clinicians make better clinical decisions.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Chinese Journal of Urology
Année:
2023
Type:
Article